General information, not medical advice or an insurance coverage decision. MedraxDME operates as an out of network supplier. Coverage, supplier enrollment requirements and patient responsibility depend on the plan and an individual review.
The differences that matter first
The standard Dexcom G7 sensor has an intended wear period of up to 10 days, with a further 12 hour grace period. G7 15 Day has up to 15 days of wear with a 12 hour grace period. Standard G7 is indicated from age 2, while G7 15 Day is indicated for adults aged 18 and older. These are intended durations, not a promise that every individual sensor will last that long. Dexcom: G7 15 Day and G7 differences.
Warmup is also different: standard G7 takes approximately 30 minutes, while G7 15 Day requires 60 minutes. The longer wear period should not be confused with the shorter warmup of standard G7. Dexcom: Healthcare professional product FAQs.
Use the complete name on the box and prescription when asking questions. Saying only “G7” can leave uncertainty about which sensor you mean. That uncertainty can affect a product comparison, an insurance review or a conversation about a compatible insulin delivery system.
A comparison without choosing for you
| Question | Dexcom G7 | Dexcom G7 15 Day |
|---|---|---|
| Intended sensor wear | Up to 10 days | Up to 15 days |
| Grace period | 12 hours | 12 hours |
| Age indication | Age 2 and older | Age 18 and older |
| Warmup | About 30 minutes | 60 minutes |
These facts come from Dexcom: G7 15 Day and G7 differences and Dexcom: Healthcare professional product FAQs. A table cannot determine which device is the best fit for an individual. Discuss age, prescribed treatment, training, skin tolerance, display preferences and any pump integration with the clinician who manages your diabetes.
There is no need to select a product because its name includes a larger number. A suitable system is one your clinician recommends, that you can use as directed and that can be obtained through an appropriate supply arrangement. Keep those practical questions separate from marketing comparisons.
A model change needs a prescription check
Dexcom states that G7 15 Day requires a new prescription. A remaining refill on a standard G7 prescription should not be treated as permission to substitute the other sensor. If you need to return to standard G7, discuss that change with your prescriber as well. Dexcom: A new prescription for G7 15 Day.
Before requesting the new prescription, ask the dispensing organization what exact model and quantity description it needs. The clinician should determine the order; the supplier can explain the administrative information needed to process it. Do not edit a prescription yourself or ask for an item to be described inaccurately to obtain coverage.
Write down which office is sending the new order and which organization should receive it. If several offices are involved, make clear whether the request is for a new device or a routine refill. This prevents a replacement request, a new prescription and an insurance authorization from being confused with one another.
Check the complete compatibility chain
A compatible phone, operating system, receiver or insulin pump is part of a specific configuration. Do not infer compatibility merely because two products both use the G7 name. Start with the current manufacturer instructions and the compatibility information for the exact connected device. The Dexcom compatibility checker is the appropriate place to check a phone and operating system.
If you use Omnipod 5, Insulet publishes a current sensor and device compatibility matrix. It distinguishes the sensor, Pod family, controller and supported phone combinations. Software support can change, so a remembered list or a screenshot from an older guide may be incomplete. Insulet: Omnipod 5 device compatibility.
Ask your clinician or trainer to confirm what will change in your existing setup before you open the new supplies. A product page is not a training session, and this comparison does not provide instructions for starting or adjusting an insulin delivery system. Follow the manuals supplied with the prescribed configuration.
Wear duration and insurance supply are different questions
A longer intended sensor life may change how many sensors correspond to a period of use. It does not by itself establish an insurer's refill authorization, the dispensing schedule or your responsibility. Those details should be reviewed using the exact prescribed product. A supplier should explain the supply period rather than rely only on a count of boxes.
Under Medicare's CGM policy, the supply allowance is a bundled benefit, and receiver use and continuing coverage requirements still matter. Changing the sensor model does not remove those requirements. CMS: Glucose Monitor policy article A52464 and CMS: Glucose Monitors coverage policy L33822.
Ask whether your plan needs a fresh authorization, whether an existing authorization applies to the new model, and how the next supply period will be calculated. If someone says the change is “covered,” clarify whether that means the product is on a covered list, your request is approved, or a claim has already been decided. Those are different stages.
Plan a transition before the last sensor
A useful transition plan identifies the final planned standard G7 supply period, the status of the new prescription, the confirmed dispensing organization and the person responsible for training questions. Do not cancel an existing supply arrangement solely because another organization has received an inquiry. First establish what has actually been approved and arranged.
Keep a personal checklist with four headings: prescription, benefits, equipment and training. Under each heading, record whether the task is complete and who can answer remaining questions. This makes a phone discussion easier than trying to recall several separate calls. It also helps a caregiver understand which action is still outstanding.
If your current sensor ends before the transition is complete, follow the monitoring plan your clinician has already provided. Ask that care team about a safe interim plan if you do not have one. Do not extend the wear period beyond labeling or reuse a sensor to bridge an administrative delay.
Support and realistic expectations
Keep the current user guide available and use the instructions for the model in your hand. Dexcom publishes separate United States guides for standard G7 and G7 15 Day. A familiar step from an older product should not replace checking the current instructions. Dexcom: Current United States user guides.
If a sensor ends early, the manufacturer reviews product issues under its replacement policy; routine insurance refills are handled through the relevant dispensing organization. These are separate processes. Record the product name and the support reference so a replacement conversation does not create uncertainty about your next normal supply request.
MedraxDME can arrange a callback about an individual insurance equipment request. The website does not promise that a switch is approved, that a device is suitable for you, or that the site is in network with your plan. Browse Dexcom G7 through insurance for the request process, and have your clinician confirm the model before the team reviews the supply arrangement.
Questions and answers
Is G7 15 Day approved for a child using standard G7?
The United States G7 15 Day indication is for adults 18 and older. Standard G7 has a different age indication. Your clinician should select the appropriate system.
Can the standard G7 prescription automatically become a G7 15 Day prescription?
Dexcom says a new prescription is required for G7 15 Day. Ask your clinician and dispensing organization to coordinate the correct order.
Does a 15 day sensor guarantee fewer interruptions?
No. Intended wear time is not a guarantee of the life of every sensor. Follow the product instructions and use manufacturer support for device problems.
Sources and updates
- Dexcom: G7 15 Day and G7 differences
- Dexcom: Healthcare professional product FAQs
- Dexcom: A new prescription for G7 15 Day
- Dexcom: Current United States user guides
- Insulet: Omnipod 5 device compatibility
- CMS: Glucose Monitor policy article A52464
- CMS: Glucose Monitors coverage policy L33822
Read our editorial and correction policy. For current plan rules, check the applicable official policy and contact your plan. Tell us about a correction.